IMP
Process View
vein smooth muscle contraction
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the vein. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The vein is a vessel carrying blood away from the capillary beds.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "vein smooth muscle contraction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.444 | ||
| CAV2 | caveolin 2 | 0.432 | ||
| EDN1 | endothelin 1 | 0.171 | ||
| EDNRA | endothelin receptor type A | 0.148 | Human | |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.144 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.074 | ||
| NID1 | nidogen 1 | 0.070 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.065 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.056 | ||
| CALCRL | calcitonin receptor-like | 0.043 | ||
| ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | 0.030 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.030 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.028 | ||
| PRRX1 | paired related homeobox 1 | 0.027 | ||
| DCN | decorin | 0.026 | ||
| SULF1 | sulfatase 1 | 0.025 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.025 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.025 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.025 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.024 | ||
| PCDH17 | protocadherin 17 | 0.020 | ||
| ASPN | asporin | 0.018 | ||
| TRIL | TLR4 interactor with leucine-rich repeats | 0.018 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.018 | ||
| CTGF | connective tissue growth factor | 0.017 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.017 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.016 | ||
| BCHE | butyrylcholinesterase | 0.016 | ||
| SNAI2 | snail homolog 2 (Drosophila) | 0.016 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.015 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.015 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.015 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.014 | ||
| FAP | fibroblast activation protein, alpha | 0.014 | ||
| EMCN | endomucin | 0.013 | ||
| P2RX6 | purinergic receptor P2X, ligand-gated ion channel, 6 | 0.013 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.013 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.013 | ||
| SOX17 | SRY (sex determining region Y)-box 17 | 0.013 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.012 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.012 | ||
| AGTR1 | angiotensin II receptor, type 1 | 0.012 | ||
| SCG2 | secretogranin II | 0.011 | ||
| KRT14 | keratin 14 | 0.011 | ||
| RND3 | Rho family GTPase 3 | 0.011 | ||
| TXNRD1 | thioredoxin reductase 1 | 0.011 | ||
| ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | 0.011 | ||
| VGF | VGF nerve growth factor inducible | 0.010 | ||
| NTM | neurotrimin | 0.010 |